1 / 5

India Mucormycosis Treatment (Black Fungus Drugs) Market

Mucormycosis (previously called as zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the air can affect the lungs and sinuses.

5186
Download Presentation

India Mucormycosis Treatment (Black Fungus Drugs) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. India Mucormycosis Treatment (Black Fungus Drugs) India Mucormycosis Treatment (Black Fungus Drugs) Market Exhibits a Stunning Growth by 2027 with Covid- Market Exhibits a Stunning Growth by 2027 with Covid- 19 Impact 19 Impact Mucormycosis (previously called as zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the air can affect the lungs and sinuses. The fungus also invades the skin through wounds such as cut, scrape, burn, or other type of skin trauma. Fungal infection may affect anyone, but they are most common in people with weakened immune systems and can occur in nearly any part of the body. Risk factors for developing mucormycosis include uncontrolled diabetes, cancer, organ transplant, neutropenia, skin trauma.  Mucormycosis needs to be treated with prescribed antifungal medication such as amphotericin B, posaconazole or isavuconazole. Amphotericin B, posaconazole, and isavuconazole are medications given intravenously. Furthermore, posaconazole and isavuconazole can also be administered orally. Apply Here For The Sample Copy Of The Report: Apply Here For The Sample Copy Of The Report: https://www.coherentmarketinsights.com/insight/request-sample/4444 India Mucormycosis Treatment (Black Fungus Drugs) Market - Impact of the India Mucormycosis Treatment (Black Fungus Drugs) Market - Impact of the Coronavirus (COVID-19) Pandemic Coronavirus (COVID-19) Pandemic The COVID-19 pandemic is expected to drive growth of the India Mucormycosis Treatment (Black Fungus Drugs) market over the forecast period, owing to increasing cases of mucormycosis infection in the COVID-19 positive or in patients

  2. who have recovered from COVID-19 infection. For instance, according to the article published in the Diabetes and Metabolic Syndrome Journal: May 21, 2021, COVID-19 infection has been associated with a wide range of bacterial and fungal infections. Currently, mucormycosis infection cases are rising in the Indian population due to the presence of ideal environment in the COVID-19 patients, low oxygen, high glucose (in case of diabetes or steroid induces hyperglycemia), acidic medium (diabetic ketoacidosis and others), high iron levels, and suppressed immune system along with other comorbidities. India Mucormycosis Treatment (Black Fungus Drugs) market is estimated to be valued at US US$ 9.1 Mn 9.1 Mn in 2021 and is expected to exhibit a CAGR of 3.5% forecast period (2021-2028). CAGR of 3.5% over the Market Players are engaged in receiving license from the Indian government, in Market Players are engaged in receiving license from the Indian government, in order to manufacture Amphotericin – B, an anti-fungal drug for the treatment of order to manufacture Amphotericin – B, an anti-fungal drug for the treatment of Black Fungus or mucormycosis. This is expected to drive growth of the India Black Fungus or mucormycosis. This is expected to drive growth of the India Mucormycosis Treatment (Black Fungus Drugs) market over the forecast period. Mucormycosis Treatment (Black Fungus Drugs) market over the forecast period. Indian government has provided license to some of the market players, in order to manufacture anti-fungal drug, Amphotericin – B for the treatment of Mucormycosis (Black Fungus Drugs). For instance, on May 22, 2021, Indian government gave license to five manufacturers: Emcure Pharmaceuticals, Natco Pharmaceuticals, Gufic Biosciences, Alembic Pharmaceuticals, and Lyca Pharmaceuticals. These companies will start producing 111,000 vials of Amphotericin – B each month from July 2021. Increasing prevalence of mucormycosis in the Indian population with comorbidities Increasing prevalence of mucormycosis in the Indian population with comorbidities is expected to drive growth of the India Mucormycosis Treatment (Black Fungus is expected to drive growth of the India Mucormycosis Treatment (Black Fungus Drugs) market Drugs) market

  3. In India, diabetes mellitus is the most common underlying disease. For instance, according to the article published in the Microorganism Journal, on March 4, 2021, the pie chart shows the percentage of mucormycosis burden in different at- risk populations in India. According to the same source, diabetes mellitus is a common predisposing factor for the rhino-orbital-cerebral mucormycosis (ROCM) type of disease. A recent study from India reported that 77% of ROCM cases were in the diabetic population. India Mucormycosis Treatment (Black Fungus Drugs) Market – Restraints India Mucormycosis Treatment (Black Fungus Drugs) Market – Restraints High cost of the medicines for the treatment of mucormycosis is expected to restrain growth of the India Mucormycosis Treatment (Black Fungus Drugs) market over the forecast period. For instance, the only antifungal drug, Amphotericin B is expensive and it will be difficult for the people to bear the cost. Currently the single vial of the drug is available in the market at a price of US$ 68.6 to US$ 109.9 (5,000 to 8,000 Indian rupees). Moreover the medicines have to be taken for 4 to 12 weeks, thus, many patients fail to take the treatment due to high cost. Government intervention may help in curbing the cost of the medicines. India Mucormycosis Treatment (Black Fungus Drugs) Market India Mucormycosis Treatment (Black Fungus Drugs) Market   – Competitive Landscape Landscape Major players operating in the India Mucormycosis Treatment (Black Fungus Drugs) market include Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences, Lyca Pharmaceuticals, Emcure Pharmaceuticals, Bharat Serums and Vaccines, BDR Pharmaceuticals, Cipla Limited, Lifecare Innovations, Synbiotics Limited, Kamla Lifesciences, Cadila Healthcare Limited, and TLC Pharma Labs Report includes chapters which deeply display the following deliverable about Report includes chapters which deeply display the following deliverable about industry : industry : • India Mucormycosis Treatment (Black Fungus Drugs) Market Research Objective and Assumption Competitive

  4. • India Mucormycosis Treatment (Black Fungus Drugs) Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • India Mucormycosis Treatment (Black Fungus Drugs) Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global India Mucormycosis Treatment (Black Fungus Drugs) Market, By Regions • India Mucormycosis Treatment (Black Fungus Drugs) Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • India Mucormycosis Treatment (Black Fungus Drugs) Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • India Mucormycosis Treatment (Black Fungus Drugs) Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • India Mucormycosis Treatment (Black Fungus Drugs) Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion

  5. Buy instant copy of this research report @ Buy instant copy of this research report @ https://www.coherentmarketinsights.com/ promo /buynow/4444 About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: sales@coherentmarketinsights.com

More Related